Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Javle

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Cancer Surveys|July 30, 2004
Radiotherapy and chemotherapy for invasive bladder cancerM Javle, D Raghavan
Cancer Treatment and Research|January 1, 1996
Total androgen blockade for prostate cancer: the end does not justify the meansM Javle, D Raghavan
British Journal of Cancer|October 13, 2011
The role of PARP in DNA repair and its therapeutic exploitationM Javle, N J Curtin
Therapeutic Advances in Medical Oncology|November 16, 2011
The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapyM Javle, N J Curtin
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Evolving strategies of cytotoxic chemotherapy for advanced prostate cancerD Raghavan, B Koczwara, M Javle
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 9, 2014
Locally advanced pancreatic cancer: the role of definitive chemoradiotherapyF Huguet, S Mukherjee, M Javle
Annals of Surgical Oncology|June 16, 2004
Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapyR Iyer, N Wilkinson, T Demmy, et al.
Postgraduate Medical Journal|August 7, 2007
Radical cystectomy: defining the threshold for a surgeon to achieve optimum outcomesJohn E McCabe, Abdullah Jibawi, Pradip M Javle
Expert Review of Gastroenterology & Hepatology|March 1, 2021
Next generation sequencing for biliary tract cancersTimothy P DiPeri, Milind M Javle, Funda Meric-Bernstam
Cancer|May 5, 2025
Poly(adenosine diphosphate ribose) polymerase inhibition in isocitrate dehydrogenase 1 and 2-mutant tumors: Bridging science with the clinicElise Nassif Haddad, Milind M Javle, Timothy A Yap
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Cancer Surveys|July 30, 2004
Radiotherapy and chemotherapy for invasive bladder cancerM Javle, D Raghavan
Cancer Treatment and Research|January 1, 1996
Total androgen blockade for prostate cancer: the end does not justify the meansM Javle, D Raghavan
British Journal of Cancer|October 13, 2011
The role of PARP in DNA repair and its therapeutic exploitationM Javle, N J Curtin
Therapeutic Advances in Medical Oncology|November 16, 2011
The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapyM Javle, N J Curtin
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Evolving strategies of cytotoxic chemotherapy for advanced prostate cancerD Raghavan, B Koczwara, M Javle
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 9, 2014
Locally advanced pancreatic cancer: the role of definitive chemoradiotherapyF Huguet, S Mukherjee, M Javle
Annals of Surgical Oncology|June 16, 2004
Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapyR Iyer, N Wilkinson, T Demmy, et al.
Postgraduate Medical Journal|August 7, 2007
Radical cystectomy: defining the threshold for a surgeon to achieve optimum outcomesJohn E McCabe, Abdullah Jibawi, Pradip M Javle
Expert Review of Gastroenterology & Hepatology|March 1, 2021
Next generation sequencing for biliary tract cancersTimothy P DiPeri, Milind M Javle, Funda Meric-Bernstam
Cancer|May 5, 2025
Poly(adenosine diphosphate ribose) polymerase inhibition in isocitrate dehydrogenase 1 and 2-mutant tumors: Bridging science with the clinicElise Nassif Haddad, Milind M Javle, Timothy A Yap
Pageof 10